HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Cai Selected Research

Angiopoietins

12/2022TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells.
9/2020Angiopoietin-1 is associated with a decreased risk of lymph node metastasis in early stage cervical cancer.
1/2020Circulating Tie2-Expressing Monocytes: A Potential Biomarker for Cervical Cancer.
7/2017Cervical cancer cell-derived angiopoietins promote tumor progression.
1/2017The ratio of serum Angiopoietin-1 to Angiopoietin-2 in patients with cervical cancer is a valuable diagnostic and prognostic biomarker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Cai Research Topics

Disease

180Neoplasms (Cancer)
05/2024 - 11/2006
40Inflammation (Inflammations)
05/2024 - 07/2014
39Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 05/2010
34Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024 - 07/2012
34Neoplasm Metastasis (Metastasis)
01/2024 - 08/2011
18Lung Neoplasms (Lung Cancer)
02/2024 - 01/2011
18Hepatocellular Carcinoma (Hepatoma)
02/2023 - 02/2011
16Nasopharyngeal Carcinoma
11/2023 - 02/2014
15Ovarian Epithelial Carcinoma
08/2023 - 04/2013
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2023 - 12/2013
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2023 - 01/2013
13Hypoxia (Hypoxemia)
01/2023 - 11/2013
12Carcinogenesis
10/2023 - 10/2010
10Carcinoma (Carcinomatosis)
01/2024 - 03/2014
9Infections
11/2023 - 01/2015
8Fibrosis (Cirrhosis)
05/2024 - 01/2016
8Esophageal Neoplasms (Esophageal Cancer)
01/2024 - 03/2014
7Breast Neoplasms (Breast Cancer)
05/2024 - 09/2010
7Type 2 Diabetes Mellitus (MODY)
01/2024 - 01/2013
7COVID-19
11/2023 - 01/2020
7Adenocarcinoma of Lung
08/2022 - 08/2019
7Diabetes Mellitus
01/2022 - 01/2013
7Esophageal Squamous Cell Carcinoma
01/2022 - 11/2013
6Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 01/2018
6Osteoporosis
03/2024 - 02/2010
6Obesity
06/2023 - 12/2016
6Body Weight (Weight, Body)
01/2023 - 01/2016
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 07/2014
6Hypertension (High Blood Pressure)
01/2022 - 01/2010
6Parkinson Disease (Parkinson's Disease)
10/2021 - 02/2012
5Atherosclerosis
05/2024 - 11/2020
5Glioma (Gliomas)
04/2024 - 01/2018
5Tuberculosis (Tuberculoses)
12/2023 - 02/2013
5Liver Neoplasms (Liver Cancer)
10/2023 - 07/2014
5Necrosis
09/2023 - 01/2013
5Pulmonary Tuberculosis
01/2022 - 01/2013
5Lymphatic Metastasis
10/2021 - 09/2010
5Insulin Resistance
01/2021 - 08/2017
5Bone Resorption
01/2021 - 10/2014
4Birth Weight (Birth Weights)
12/2023 - 09/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 01/2011
4Prostatic Neoplasms (Prostate Cancer)
11/2023 - 05/2014
4Cognitive Dysfunction
10/2023 - 09/2014
4Wounds and Injuries (Trauma)
09/2023 - 12/2010
4Disease Susceptibility (Diathesis)
12/2022 - 09/2018

Drug/Important Bio-Agent (IBA)

48Proteins (Proteins, Gene)FDA Link
01/2024 - 09/2010
32Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2013
18Particulate MatterIBA
05/2024 - 10/2016
17Cisplatin (Platino)FDA LinkGeneric
03/2024 - 10/2010
16MicroRNAs (MicroRNA)IBA
05/2023 - 05/2010
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2023 - 11/2009
12PlatinumIBA
03/2024 - 01/2013
12GlucocorticoidsIBA
07/2023 - 12/2013
11ErbB Receptors (EGF Receptor)IBA
01/2024 - 11/2006
10Glucose (Dextrose)FDA LinkGeneric
04/2024 - 02/2013
10Antiviral Agents (Antivirals)IBA
01/2023 - 02/2016
10CytokinesIBA
03/2022 - 01/2013
9DNA (Deoxyribonucleic Acid)IBA
03/2024 - 01/2015
9Therapeutic UsesIBA
08/2023 - 01/2013
8Small Interfering RNA (siRNA)IBA
12/2023 - 09/2010
8IronIBA
10/2023 - 05/2015
8Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 05/2010
7Oxygen (Dioxygen)IBA
04/2024 - 04/2016
7Messenger RNA (mRNA)IBA
02/2018 - 05/2010
6Matrix Metalloproteinases (MMPs)IBA
01/2024 - 02/2014
6EnzymesIBA
11/2023 - 11/2013
6Long Noncoding RNAIBA
12/2022 - 05/2018
6Caspase 3 (Caspase-3)IBA
06/2021 - 02/2012
5LipidsIBA
05/2024 - 06/2020
5RNA (Ribonucleic Acid)IBA
04/2024 - 01/2019
5Peptides (Polypeptides)IBA
01/2023 - 01/2017
5Interleukin-6 (Interleukin 6)IBA
12/2022 - 10/2012
5AngiopoietinsIBA
12/2022 - 01/2017
5Phosphotransferases (Kinase)IBA
11/2022 - 02/2011
5osimertinibIBA
06/2022 - 01/2021
5Cadherins (E-Cadherin)IBA
01/2022 - 12/2010
5VimentinIBA
10/2021 - 08/2011
5Enhancer of Zeste Homolog 2 ProteinIBA
06/2018 - 04/2013
5Capsules (Microcapsules)IBA
04/2017 - 09/2003
4IntegrinsIBA
01/2024 - 01/2020
4Conditioned Culture MediaIBA
01/2024 - 11/2014
4Epidermal Growth Factor (EGF)IBA
01/2024 - 01/2020
4OzoneIBA
12/2023 - 01/2018
4CateninsIBA
02/2023 - 08/2011
4LipopolysaccharidesIBA
01/2023 - 01/2015
4Angiopoietin-2IBA
12/2022 - 01/2017

Therapy/Procedure

73Radiotherapy
04/2024 - 07/2007
42Therapeutics
02/2024 - 01/2013
32Drug Therapy (Chemotherapy)
04/2024 - 10/2010
13Immunotherapy
04/2024 - 08/2012
11Hysterectomy
01/2023 - 01/2015
10Neoadjuvant Therapy
05/2024 - 07/2012
8Lymph Node Excision (Lymph Node Dissection)
01/2023 - 01/2015
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2010
7Oncolytic Virotherapy
01/2021 - 02/2016
6Chemoradiotherapy
12/2023 - 03/2014
6Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2022 - 07/2007
5Intraperitoneal Injections
08/2023 - 02/2012
5Adjuvant Chemotherapy
07/2023 - 01/2021
4Brachytherapy
05/2024 - 04/2016